MDT

82.53

-3.2%↓

122

+0.95%↑

VEEV

167.85

-0.65%↓

HQY

83.95

-2.51%↓

NEOG

9.42

-2.18%↓

MDT

82.53

-3.2%↓

122

+0.95%↑

VEEV

167.85

-0.65%↓

HQY

83.95

-2.51%↓

NEOG

9.42

-2.18%↓

MDT

82.53

-3.2%↓

122

+0.95%↑

VEEV

167.85

-0.65%↓

HQY

83.95

-2.51%↓

NEOG

9.42

-2.18%↓

MDT

82.53

-3.2%↓

122

+0.95%↑

VEEV

167.85

-0.65%↓

HQY

83.95

-2.51%↓

NEOG

9.42

-2.18%↓

MDT

82.53

-3.2%↓

122

+0.95%↑

VEEV

167.85

-0.65%↓

HQY

83.95

-2.51%↓

NEOG

9.42

-2.18%↓

Kodu・Aktsiate loetelu・Schrodinger Inc

Schrodinger Inc

Suletud

SektorTervishoid

12.84 0.71

Osta Müü

Ülevaade

Aktsiahinna muutus

24h

Praegune

Min

12.7

Max

13.29

Põhinäitajad
By Trading Economics
Sissetulek	169M 136M
Müük	33M 87M
Aktsiakasum	-0.18
Kasumimarginaal	155.644
Töötajad	850
EBITDA	67M 36M

Soovitused
By TipRanks
Soovitused	Tugev "osta" hinnang
12 kuu keskmine prognoos	+42.58% upside

Dividendid
By Dow Jones
Järgmine tulemuste avaldamine	5. mai 2026

Turustatistika
By TradingEconomics
Turukapital	118M 945M
Eelmine avamishind	12.13
Eelmine sulgemishind	12.84

Uudiste sentiment

By Acuity

77%

23%

331 / 348 Pingereas Healthcare

Tehniline skoor

By Trading Central

Kindlus

Very Strong Bearish Evidence

23.27 / 26.13 Toetus ja vastupanu

Schrodinger Inc Graafik

Mineviku tootlus ei ole usaldusväärne näitaja tulevaste tulemuste kohta.

Seotud uudised

21. apr 2026, 23:27 UTC

Uudisväärsed sündmused

BHP Expects Annual Copper Output in Upper Half of Guidance, Finishes China Iron-Ore Negotiations

21. apr 2026, 23:27 UTC

Kuumad aktsiad

Stocks to Watch: Sonoco Products, Adobe, Manhattan Associates, Target Hospitality

21. apr 2026, 23:02 UTC

Tulu

Correction to Capital One Financial 1Q Earnings Article

21. apr 2026, 23:47 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

21. apr 2026, 23:47 UTC

Market Talk

Nikkei May Decline as Hopes for U.S.-Iran Peace Talks Fade

21. apr 2026, 23:36 UTC

Market Talk

Uudisväärsed sündmused

Market Talk Roundup: Latest on U.S. Politics

21. apr 2026, 23:36 UTC

Market Talk

Uudisväärsed sündmused

Gold Edges Higher After Trump Says U.S. Will Extend Cease-Fire Deadline -- Market Talk

21. apr 2026, 23:32 UTC

Tulu

America Movil 1Q EBITDA MXN94.5B, Up 3.8% on Year >AMX

21. apr 2026, 23:30 UTC

Tulu

America Movil 1Q Rev MXN236.84B, Up 2.1% on Year >AMX

21. apr 2026, 23:28 UTC

Tulu

America Movil 1Q Net MXN23.4B Vs. Net MXN18.7B >AMX

21. apr 2026, 23:16 UTC

Uudisväärsed sündmused

Ampol Entered 2Q With Hedge Book Positioned to Mitigate Volatility

21. apr 2026, 23:15 UTC

Uudisväärsed sündmused

Ampol Entered 2Q With Broad-Based Momentum

21. apr 2026, 23:15 UTC

Uudisväärsed sündmused

Ampol: Suitable Crudes for Lytton Remain Available in Market

21. apr 2026, 23:14 UTC

Uudisväärsed sündmused

Ampol: Crude Supplies Secured Into July

21. apr 2026, 23:14 UTC

Uudisväärsed sündmused

Ampol: Fuel Supplies Secured Until at Least End of May

21. apr 2026, 23:13 UTC

Uudisväärsed sündmused

Ampol: Well Placed for Crude, Product Supply Prior to Iran Conflict

21. apr 2026, 23:13 UTC

Uudisväärsed sündmused

Ampol 1Q Lytton Refinery Production 1.43 Billion Liters

21. apr 2026, 23:12 UTC

Uudisväärsed sündmused

Ampol 1Q Lytton Refiner Margin US$25.45/Bbl

21. apr 2026, 22:54 UTC

Market Talk

Sell America Trade Could Gain Momentum If Fed Uncertainty Unresolved -- Market Talk

21. apr 2026, 22:49 UTC

Uudisväärsed sündmused

BHP 3Q Average Realized Energy Coal Price $105.61/Ton, Up 10% On-Quarter

21. apr 2026, 22:49 UTC

Uudisväärsed sündmused

BHP 3Q Average Realized Steelmaking Coal Price $226.76/Ton, Up 15% On-Quarter

21. apr 2026, 22:48 UTC

Uudisväärsed sündmused

BHP 3Q Average Realized Iron Ore Price $85.35/Ton, Flat On-Quarter

21. apr 2026, 22:48 UTC

Omandamised, ülevõtmised, äriostud

Alliance Portfolio Is Comprised of Five Plants: Batavia, Hillburn, Massena, Shoemaker and Sterling

21. apr 2026, 22:48 UTC

Uudisväärsed sündmused

BHP 3Q Average Realized Copper Price $5.86/Pound, Down 1% On-Quarter

21. apr 2026, 22:48 UTC

Omandamised, ülevõtmised, äriostud

PowerTransitions to Buy 323 MW of Power Generation Assets in New York State From Alliance Energy Group

21. apr 2026, 22:46 UTC

Uudisväärsed sündmused

BHP: Has Concluded Iron Ore Sales Contract Negotiations With China Mineral Resources Group

21. apr 2026, 22:45 UTC

Uudisväärsed sündmused

BHP: Pampa Norte Production Down on Ore Complexity, Variation; Declining Grades

21. apr 2026, 22:45 UTC

Uudisväärsed sündmused

BHP: Escondida Concentrator Investment Estimated Between $4.4 Billion-$5.9 Billion

21. apr 2026, 22:44 UTC

Uudisväärsed sündmused

BHP: Escondida Concentrator Project Seen Facing FID in 2027-28

21. apr 2026, 22:42 UTC

Uudisväärsed sündmused

BHP CEO: Centralized Procurement, Low-cost Operations Help Buffer Industry Wide Cost Pressures

Võrdlus sarnastega

Hinnamuutus

Schrodinger Inc Prognoos

Hinnasiht

By TipRanks

42.58% tõus

12 kuu keskmine prognoos

Keskmine 18.25 USD 42.58%

Kõrge 20 USD

Madal 13 USD

Põhineb 5 Wall Streeti analüütiku instrumendi Schrodinger Inc 12 kuu hinnasihil - viimase 3 kuu andmed.

Hinnangu Konsensus

By TipRanks

Tugev "osta" hinnang

5 ratings

Osta

Hoia

Müü

Põhineb 5 analüütiku instrumendi Schrodinger Inc aktsia reitingul - viimase 3 kuu andmed.

Tehniline skoor

By Trading Central

23.27 / 26.13Toetus ja vastupanu

Recent bearish events outweigh bullish events.

All events are bullish.

Sentiment

By Acuity

331 / 348 Pingereas Tervishoid

Finantsandmed

Müügi- ja halduskulud

Tegevuskulud

Maksueelne kasum

Müük

Müügikulu

Brutokasum müügist

Intressikulud võla pealt

EBITDA

Ärikasum

Ettevõttest Schrodinger Inc

Schrödinger, Inc., together with its subsidiaries, develops physics-based computational platform that enables discovery of novel molecules for drug development and materials applications. The company operates in two segments, Software and Drug Discovery. The Software segment is focused on licensing its software to transform molecular discovery for life sciences and materials science industries. The Drug Discovery segment focuses on building a portfolio of preclinical and clinical programs, internally and through collaborations. The company serves biopharmaceutical and industrial companies, academic institutions, and government laboratories worldwide. It has a research collaboration and license agreement with Novartis AG to advance multiple development candidates. Schrödinger, Inc. was incorporated in 1990 and is based in New York, New York.